+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Patient Monitoring Devices Market (2022-2027) by Product, End-Users, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon


  • 190 Pages
  • May 2022
  • Region: Global
  • Infogence Global Research
  • ID: 5635997
UP TO OFF until Dec 31st 2023

Increasing trend of remote-monitoring is boosting the market growth

The Global Patient Monitoring Devices Market is estimated to be USD 45.65 Bn in 2022 and is expected to reach USD 84.29 Bn by 2027, growing at a CAGR of 13.05%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Patient Monitoring Devices Market is segmented based on Product, End-Users, and Geography.
  • By Product, the market is classified into Blood Glucose Monitoring Systems, Continuous Glucose Monitoring Systems, Self-monitoring Blood Glucose Systems, Cardiac Monitoring Devices, Fetal & Neonatal Monitoring Devices, Hemodynamic/Pressure Monitoring Devices, Multi-parameter Monitoring Devices, Neuromonitoring Devices, Respiratory Monitoring Devices, and Temperature Monitoring Devices.
  • By End-Users, the market is classified into Ambulatory Surgery Centers, Home Care Settings, and Hospitals.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are 100 Plus, Abbott Laboratories, BIOTRONIK SE & Co. KG, Boston Scientific Corp, Cardiomo, Inc.,, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Patient Monitoring Devices Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the Global Patient Monitoring Devices Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Patient Monitoring Devices Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including the parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Patient Monitoring Devices Market

What is the estimated value of the Global Patient Monitoring Devices Market?

The Global Patient Monitoring Devices Market was estimated to be valued at $45.65 Billion in 2022.

What is the growth rate of the Global Patient Monitoring Devices Market?

The growth rate of the Global Patient Monitoring Devices Market is 13.0%, with an estimated value of $84.29 Billion by 2027.

What is the forecasted size of the Global Patient Monitoring Devices Market?

The Global Patient Monitoring Devices Market is estimated to be worth $84.29 Billion by 2027.

Who are the key companies in the Global Patient Monitoring Devices Market?

Key companies in the Global Patient Monitoring Devices Market include 100 Plus, Abbott Laboratories, BIOTRONIK SE & Co. KG, Boston Scientific Corp, Cardiomo, Inc ChroniSense Medical Ltd, Compumedics Limited, Dexcom Inc, Drägerwerk AG & Co. KGaA, Edwards Lifesciences Corp and GE Healthcare.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Rising Prevalence of Chronic Diseases
4.1.2 Increasing Preference for Wearable Patient Monitoring Devices
4.2 Restraints
4.2.1 Risks Associated with Invasive Monitoring Devices
4.2.2 High Cost of Patient Monitoring Products
4.3 Opportunities
4.3.1 Growing Market for Non-Invasive and Minimally Invasive Devices
4.3.2 Increasing Demand for Patient Monitoring Devices in Non-Hospital Settings
4.4 Challenges
4.4.1 Lack of Skilled Healthcare Professionals
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Patient Monitoring Devices Market, By Product
6.1 Introduction
6.2 Blood Glucose Monitoring Systems
6.3 Continuous Glucose Monitoring Systems
6.4 Self-monitoring Blood Glucose Systems
6.5 Cardiac Monitoring Devices
6.6 Fetal & Neonatal Monitoring Devices
6.7 Hemodynamic/Pressure Monitoring Devices
6.8 Multi-parameter Monitoring Devices
6.9 Neuromonitoring Devices
6.10 Respiratory Monitoring Devices
6.11 Temperature Monitoring Devices
7 Global Patient Monitoring Devices Market, By End-Users
7.1 Introduction
7.2 Ambulatory Surgery Centers
7.3 Home Care Settings
7.4 Hospitals
8 Americas' Patient Monitoring Devices Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe's Patient Monitoring Devices Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa's Patient Monitoring Devices Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC's Patient Monitoring Devices Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 100 Plus
13.2 Abbott Laboratories
13.4 Boston Scientific Corp
13.5 Cardiomo, Inc
13.6 ChroniSense Medical Ltd
13.7 Compumedics Limited
13.8 Dexcom Inc
13.9 Drägerwerk AG & Co. KGaA
13.10 Edwards Lifesciences Corp
13.11 GE Healthcare
13.12 Getinge AB
13.13 Hill-Rom Holdings, Inc
13.14 Koninklijke Philips N.V.
13.15 Masimo Corp
13.16 Medtronic PLC
13.17 Mindray Medical International Limited
13.18 Natus Medical
13.19 Nihon Kohden Corp
13.20 Nonin Medical Inc
13.21 Omron Corp
13.22 Schiller AG
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • 100 Plus
  • Abbott Laboratories
  • Boston Scientific Corp
  • Cardiomo, Inc ChroniSense Medical Ltd
  • Compumedics Limited
  • Dexcom Inc
  • Drägerwerk AG & Co. KGaA
  • Edwards Lifesciences Corp
  • GE Healthcare
  • Getinge AB
  • Hill-Rom Holdings, Inc Koninklijke Philips N.V.
  • Masimo Corp
  • Medtronic PLC
  • Mindray Medical International Limited
  • Natus Medical
  • Nihon Kohden Corp
  • Nonin Medical Inc
  • Omron Corp
  • Schiller AG